GlassScriptPhysician profile
Carlos Corvera
NPI 1336166396
$24,894.08
in general payments reported to CMS, 2019-2025
6 companies · $4,028 in 2025
The $4,028 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2021: $1,960 · 2023: $341 · 2024: $431 · 2025: $4,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Travel and Lodging: $1,481 · Food and Beverage: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $1,480.72 |
| Food and Beverage | $1,319.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $12,891.93 | 2019-2025 | Neuwave, Certus 140 |
| Medical Device Business Services, INC. | $5,785.00 | 2019-2021 | |
| Histosonics, INC. | $3,550.19 | 2025 | |
| Intuitive Surgical, INC. | $1,932.30 | 2019-2024 | |
| Dilon Technologies, INC. | $595.03 | 2023-2025 | Hemoblast Bellows |
| Boston Scientific Corporation | $139.63 | 2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Corvera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.